Response to the Comment by Cirasino L and Semeraro S: “Need to direct immune thrombocytopenia therapy towards shared goals” Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia in adults

• Yasuyuki Arai,
• Tomoyasu Jo,
• Hiroyuki Matsui,
• Tadakazu Kondo,
• Akifumi Takaori-Kondo

Affiliations

Yasuyuki Arai

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan;Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Tomoyasu Jo

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan

Hiroyuki Matsui

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan

Tadakazu Kondo

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan

Akifumi Takaori-Kondo

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan